148 related articles for article (PubMed ID: 19661995)
1. Chromatographic assays of drug oxidation by human cytochrome P450 3A4.
Sohl CD; Cheng Q; Guengerich FP
Nat Protoc; 2009; 4(9):1252-7. PubMed ID: 19661995
[TBL] [Abstract][Full Text] [Related]
2. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
[TBL] [Abstract][Full Text] [Related]
3. Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4/NADPH-cytochrome P450 reductase system and studies with apo-cytochrome b5.
Yamazaki H; Johnson WW; Ueng YF; Shimada T; Guengerich FP
J Biol Chem; 1996 Nov; 271(44):27438-44. PubMed ID: 8910324
[TBL] [Abstract][Full Text] [Related]
4. Testosterone 1 beta-hydroxylation by human cytochrome P450 3A4.
Krauser JA; Voehler M; Tseng LH; Schefer AB; Godejohann M; Guengerich FP
Eur J Biochem; 2004 Oct; 271(19):3962-9. PubMed ID: 15373842
[TBL] [Abstract][Full Text] [Related]
5. Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liver.
Shou M; Martinet M; Korzekwa KR; Krausz KW; Gonzalez FJ; Gelboin HV
Pharmacogenetics; 1998 Oct; 8(5):391-401. PubMed ID: 9825831
[TBL] [Abstract][Full Text] [Related]
6. An ultra-high performance liquid chromatography-tandem mass spectrometric assay for quantifying 3-ketocholanoic acid: Application to the human liver microsomal CYP3A-dependent lithocholic acid 3-oxidation assay.
Bansal S; Chai SF; Lau AJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1023-1024():1-8. PubMed ID: 27153105
[TBL] [Abstract][Full Text] [Related]
7. Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH--cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates.
Yamazaki H; Ueng YF; Shimada T; Guengerich FP
Biochemistry; 1995 Jul; 34(26):8380-9. PubMed ID: 7599128
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 3A4-catalyzed testosterone 6beta-hydroxylation stereochemistry, kinetic deuterium isotope effects, and rate-limiting steps.
Krauser JA; Guengerich FP
J Biol Chem; 2005 May; 280(20):19496-506. PubMed ID: 15772082
[TBL] [Abstract][Full Text] [Related]
9. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
[TBL] [Abstract][Full Text] [Related]
10. Mechanism-based inactivation of cytochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction and covalent binding to protein.
Lin HL; Kent UM; Hollenberg PF
J Pharmacol Exp Ther; 2002 Apr; 301(1):160-7. PubMed ID: 11907170
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous evaluation of substrate-dependent CYP3A inhibition using a CYP3A probe substrates cocktail.
Lee E; Shon JC; Liu KH
Biopharm Drug Dispos; 2016 Sep; 37(6):366-72. PubMed ID: 27323294
[TBL] [Abstract][Full Text] [Related]
12. Inhibition and activation of the human liver microsomal and human cytochrome P450 3A4 metabolism of testosterone by deployment-related chemicals.
Usmani KA; Rose RL; Hodgson E
Drug Metab Dispos; 2003 Apr; 31(4):384-91. PubMed ID: 12642463
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human cytochrome P450 3A4 by cholesterol.
Shinkyo R; Guengerich FP
J Biol Chem; 2011 May; 286(21):18426-33. PubMed ID: 21471209
[TBL] [Abstract][Full Text] [Related]
15. Development of a non-high pressure liquid chromatography assay to determine testosterone hydroxylase (CYP3A) activity in human liver microsomes.
Draper AJ; Madan A; Smith K; Parkinson A
Drug Metab Dispos; 1998 Apr; 26(4):299-304. PubMed ID: 9531515
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-cytochrome P450 oxidoreductase, and cytochrome b5.
Inui H; Maeda A; Ohkawa H
Biochemistry; 2007 Sep; 46(35):10213-21. PubMed ID: 17691855
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cytochrome P450-mediated bioactivation of a compound containing the chemical scaffold, 4,5-dihydropyrazole-1-carboxylic acid-(4-chlorophenyl amide), to a chemically reactive p-chlorophenyl isocyanate intermediate in human liver microsomes.
Chen H; Zientek M; Jalaie M; Zhang Y; Bigge C; Mutlib A
Chem Res Toxicol; 2009 Sep; 22(9):1603-12. PubMed ID: 19697924
[TBL] [Abstract][Full Text] [Related]
18. Validation of higher-throughput high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry assays to conduct cytochrome P450s CYP2D6 and CYP3A4 enzyme inhibition studies in human liver microsomes.
Chu I; Favreau L; Soares T; Lin Cc; Nomeir AA
Rapid Commun Mass Spectrom; 2000; 14(4):207-14. PubMed ID: 10669878
[TBL] [Abstract][Full Text] [Related]
19. Marmoset Cytochrome P450 3A4 Ortholog Expressed in Liver and Small-Intestine Tissues Efficiently Metabolizes Midazolam, Alprazolam, Nifedipine, and Testosterone.
Uehara S; Uno Y; Nakanishi K; Ishii S; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2017 May; 45(5):457-467. PubMed ID: 28196829
[TBL] [Abstract][Full Text] [Related]
20. Thin-layer chromatography analysis of human CYP3A-catalyzed testosterone 6beta-hydroxylation.
Waxman DJ; Chang TK
Methods Mol Biol; 2006; 320():133-41. PubMed ID: 16719384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
